Efavirenz-induced decrease in plasma amprenavir levels in human immunodeficiency virus-infected patients and correction by ritonavir

Antimicrob Agents Chemother. 2000 Sep;44(9):2593. doi: 10.1128/AAC.44.9.2593-2593.2000.
No abstract available

Publication types

  • Letter

MeSH terms

  • Alkynes
  • Anti-HIV Agents / blood*
  • Anti-HIV Agents / pharmacology
  • Anti-HIV Agents / therapeutic use
  • Aryl Hydrocarbon Hydroxylases*
  • Benzoxazines
  • Carbamates
  • Cyclopropanes
  • Cytochrome P-450 CYP3A
  • Cytochrome P-450 Enzyme Inhibitors
  • Drug Interactions
  • Drug Therapy, Combination
  • Furans
  • HIV Infections / blood*
  • HIV Infections / drug therapy
  • Humans
  • Oxazines / pharmacology*
  • Oxazines / therapeutic use
  • Oxidoreductases, N-Demethylating / antagonists & inhibitors
  • Ritonavir / pharmacology*
  • Ritonavir / therapeutic use
  • Sulfonamides / blood*
  • Sulfonamides / therapeutic use

Substances

  • Alkynes
  • Anti-HIV Agents
  • Benzoxazines
  • Carbamates
  • Cyclopropanes
  • Cytochrome P-450 Enzyme Inhibitors
  • Furans
  • Oxazines
  • Sulfonamides
  • amprenavir
  • Aryl Hydrocarbon Hydroxylases
  • Cytochrome P-450 CYP3A
  • Oxidoreductases, N-Demethylating
  • efavirenz
  • Ritonavir